DCSSC

Clinical trials for DCSSC explained in plain language.

Never miss a new study

Get alerted when new DCSSC trials appear

Sign up with your email to follow new studies for DCSSC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New antibody drug takes aim at autoimmune diseases

Disease control Recruiting now

This early-stage study tests a new drug called SAR448501 (DR-0201) in 62 adults with lupus or rheumatoid arthritis. The drug is a bispecific antibody designed to target the immune system. The main goal is to check safety and find the right dose, not yet to prove it works. Partici…

Matched conditions: DCSSC

Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

DCSSC

Get alerted when new DCSSC trials appear

New antibody drug takes aim at autoimmune diseases